Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Lancet

• Publication date

  2017-12-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(17)32448-0PMID 29050646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010

  2017cited by this paper
• Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.

  2017cited by this paper
• Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China.

  2016cited by this paper
• Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.

  2016cited by this paper
• 78 Incidence and Phenotype of Inflammatory Bowel Disease From 13 Countries in Asia-Pacific: Results From the Asia-Pacific Crohn's and Colitis Epidemiologic Study 2011-2013

  2016cited by this paper
• Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia

  2016cited by this paper
• The Rising Burden of Inflammatory Bowel Disease in North America from 2015 to 2025: A Predictive Model: 1959

  2015cited by this paper
• Inflammatory Bowel Disease in Immigrants to Canada And Their Children: A Population-Based Cohort Study

  2015cited by this paper
• Asthma, Type 1 and Type 2 Diabetes Mellitus, and Inflammatory Bowel Disease amongst South Asian Immigrants to Canada and Their Children: A Population-Based Cohort Study

  2015cited by this paper
• The global burden of IBD: from 2015 to 2025

  2015cited by this paper
• Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012: A Nationwide Population-based Study

  2015cited by this paper
• Nationwide prevalence of inflammatory bowel disease in Sweden: a population‐based register study

  2014cited by this paper
• Changing Age Demographics of Inflammatory Bowel Disease in Ontario, Canada: A Population-based Cohort Study of Epidemiology Trends

  2014cited by this paper
• Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort

  2014cited by this paper
• The burden of inflammatory bowel disease in Europe.

  2013cited by this paper
• Epidemiology and clinical presentation of inflammatory bowel disease in Zadar County, Croatia.

  2013cited by this paper
• Environment and the inflammatory bowel diseases.

  2013cited by this paper
• Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

  2012cited by this paper
• Inflammatory bowel disease: a Canadian burden of illness review.

  2012cited by this paper
• Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases

  2011cited by this paper
• Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

  2011cited by this paper
• Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina between 1995 and 2006: epidemiological and clinical characteristics

  2010cited by this paper
• Fine‐scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables

  2010cited by this paper
• Inflammatory bowel disease: cause and immunobiology

  2007cited by this paper
• High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study

  2006cited by this paper
• Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data

  2006cited by this paper
• Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002

  2006cited by this paper
• The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study

  2006cited by this paper
• Consensus Statement

  2004cited by this paper
• Epidemiology of inflammatory bowel disease in the Songpa‐Kangdong district, Seoul, Korea, 1986–2005: A KASID study

  2003cited by this paper
• Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England

  2003cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Regional ileitis; a pathologic and clinical entity.

  1952cited by this paper

• Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis

  2026cites this paper
• Whole-Food Dietary Interventions in Crohn’s Disease: A Literature Review

  2026cites this paper
• Epidemiology of inflammatory bowel disease in southern Spain - A population-based study of native and migrant populations (2012-2022).

  2026cites this paper
• Development and evaluation of a machine learning model to predict unplanned readmission risk in patients with ulcerative colitis

  2026cites this paper
• UHRF1 deficiency exacerbates intestinal inflammation by epigenetic modulation of NPY1R gene methylation

  2026cites this paper
• 7,8-Dihydroxyflavone alleviates ulcerative colitis by binding keap1 to activate an slc7a11-dependent inhibition of NF-κB p65 signaling in macrophages.

  2026cites this paper
• Engineered prebiotic microcapsules Co-Encapsulating berberine and curcumin Elicit multi-synergistic therapy for ulcerative colitis

  2026cites this paper
• Diagnosis of Pediatric Inflammatory Bowel Disease (PIBD)–Implications for the Asia-Pacific Region: A Position Paper from the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition PIBD Working Group

  2026cites this paper
• AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review.

  2026cites this paper
• Crohn's Disease in Malaysia: Could Application of the Precautionary Principle Reduce Future Incidence?

  2026cites this paper
• Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune Thyroiditis.

  2026cites this paper
• Comparable efficacy and mechanisms of sterile soil ingestion versus low hygiene exposure in DSS-induced colitis

  2026cites this paper
• Possible underdiagnosis of ulcerative colitis in tertiary care can affect medication use and access to healthcare facilities.

  2026cites this paper
• Huangtu Decoction regulates macrophage M1/M2 polarization to alleviate DSS- and rhubarb-induced Deficiency-Cold Pattern in Ulcerative Colitis by inhibiting the HIF-1α signaling pathway.

  2026cites this paper
• Polydopamine-encapsulated modified Pulsatilla decoction: a strategy to enhance ulcerative colitis therapy

  2026influential citation
• Disease Clearance Reduces the Risk of Adverse Outcomes and Provides Additional Benefit Beyond Individual Clinical, Endoscopic, or Histological Remission in Ulcerative Colitis

  2026cites this paper
• YTHDF1 Drives Ferroptosis in Ulcerative Colitis via m6A‐ACSL4 Stabilization

  2026cites this paper
• cGAS-STING signaling: a therapeutic target in inflammatory bowel disease and related colorectal cancer

  2026cites this paper
• Transcription factor PITX2 protects intestinal epithelial cells against inflammatory stress: Implications for ulcerative colitis rectal predilection and therapeutic resistance.

  2026cites this paper
• The dual role of TRPA1 in dextran sulfate sodium (DSS)-induced murine colitis: Suppression alleviates acute inflammation but exacerbates subacute disease.

  2026cites this paper
• A Nanosheet-Anchored Hydrogel System: An Injectable Platform for Herbs Polyphenols in Treating Ulcerative Colitis.

  2026cites this paper
• An in situ therapeutic vaccine for targeted treatment of ulcerative colitis via induction and maintenance of long-term immune tolerance

  2026cites this paper
• Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

  2026cites this paper
• Nanomedicine Strategies for Autoimmune Diseases: Targeting and Reprogramming Macrophages.

  2026cites this paper
• Research Advances and Model Selection Considerations in Mouse Models of Ulcerative Colitis

  2026cites this paper
• A Review of the Use of Mobile Health Interventions in Patients with Inflammatory Bowel Disease

  2026cites this paper
• Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity.

  2026cites this paper
• The Effects of Microbiome Modulating Therapies on Inflammatory Markers in Autoimmune Disease: A Systematic Review and Meta-Analysis.

  2026cites this paper
• A mathematical model to simulate the biological action of Infliximab on TNF-\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{docum

  2026cites this paper
• Global, regional, and national burdens of colorectal cancer and inflammatory bowel disease, 1990-2021 and projections to 2050: a cross-sectional study.

  2026cites this paper
• Road to IBD prevention in the Global South: a conceptual framework modelling from non-communicable diseases

  2026cites this paper
• Protective Effects of Herbacetin in Experimental Colitis: Targeting NF‐κB and NLRP3 Pathways

  2026cites this paper
• Phenotype-specific determinants of health-related quality of life in Crohn’s disease and ulcerative colitis: a multicenter cross-sectional study

  2026cites this paper
• NUTRITIONAL ASSESSMENT AND ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN COLOMBIA: NUTRIBD - COL

  2026cites this paper
• The value of platelet-associated parameters as biomarkers in evaluating the disease activity of inflammatory bowel disease: a systematic review and meta-analysis

  2026influential citation
• B cell pathways implicate shared genetic architecture between schizophrenia and immune-mediated diseases

  2026cites this paper
• Loss of LXRβ Drives CD4+ T Cell Senescence and Exacerbates the Progression of Colitis

  2026cites this paper
• Liver enzyme alterations during pregnancy in IBD are not attributable to disease activity or medication

  2026influential citation
• Accelerating burden of paediatric IBD in UAE: phenotypes and treatment patterns at a single centre (2012–2024)

  2026cites this paper
• Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy

  2026cites this paper
• The Impact of H1–H4 Receptor Antagonists on the Levels of Selected Oxidative Stress Markers in Liver and Muscle Tissue in an Animal Model of Colitis

  2026cites this paper
• A Prussian Blue Nanozyme-Adjuvanted Vaccine Presenting Phosphocholine Antigens for Induction of Immunotolerance in Inflammatory Bowel Disease.

  2026cites this paper
• Global bibliometric analysis of comorbid depression and anxiety in inflammatory bowel disease (2010–2024)

  2026influential citation
• Clinical Effectiveness and Safety of Chinese Herbal Enema for Ulcerative Colitis: An Evidence-Based Study.

  2026cites this paper
• The impact of probiotics and microbiome-targeted therapy on Crohn’s disease improvement: A systematic review

  2026cites this paper
• Alleviation of Ulcerative Colitis in Mice by Individual Fermentation of Periplaneta americana Powder with L. bulgaricus SN22 and S. thermophilus SN05.

  2026cites this paper
• Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects

  2026cites this paper
• Zinc Deficiency Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

  2026cites this paper
• Association between "Life's Critical 9" health score and the risk of inflammatory bowel disease: a prospective cohort study from the UK biobank.

  2026cites this paper
• Adipokine CTRP12 Alleviates Experimental Colitis by Participating in Modulating Mesenteric M2 Macrophage Polarization in IL-10 KO Mice.

  2026cites this paper
• Challenges and Prospects of Using Novel Nonlinear Effects in Multimode Optical Fibers for Multiphoton Endomicroscopy

  2026cites this paper
• Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease

  2026influential citation
• Analysis of MIR155HG gene polymorphisms and ulcerative colitis susceptibility in the Chinese Han Population.

  2026cites this paper
• Genome Instability and Somatic Mutagenesis in Autoimmune Diseases

  2026cites this paper
• Milk Kefir Beverage Improves Histomorphometry, Reduces Inflammatory Infiltrates and Desulfovibrio and Increases Lactobacillus in IL‐10−/− Mice

  2026cites this paper
• Sex and the Developmental Environment Shape Molecular Networks Underlying Bronchial Responsiveness in Mice

  2026cites this paper
• Undaria pinnatifida Polysaccharide Ameliorates DSS-Induced Murine Colitis by Regulating Intestinal Inflammation, Gut Microbiota and Metabolism.

  2026cites this paper
• The Gut Microbiome as a Modulator of Antibiotic Resistance: Mechanisms, Dynamics, and Therapeutic Interventions.

  2026cites this paper
• Disease Activity and Psychosocial Factors Associated with Heath-Related Quality of Life in Patients with Crohn's Disease: A Cross-Sectional Study.

  2026cites this paper
• Genomic and functional characterization of probiotic strains from traditional fermented dairy products in alleviating dextran sulfate sodium-induced colitis.

  2026cites this paper
• Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the Phase 3 GRAVITI study.

  2026cites this paper
• Histological interpretation and reporting of intestinal mucosal biopsies in suspected cases of inflammatory bowel disease: Joint IAPM-ISG-CCFI Working Group Recommendations.

  2026cites this paper
• ESTROGEN IMPACTS NOD2-DEPENDENT REGULATION OF INTESTINAL HOMEOSTASIS

  2026cites this paper
• Endodontic Inflammatory Disease: Systemic Consequences.

  2026cites this paper
• Microbial signature of pediatric Crohn's disease: Differentiation from functional gastrointestinal disorders and relationship with increased disease activity

  2026cites this paper
• Mucosally sourced complement factor B modulates the host response to colitis

  2026cites this paper
• Maqian (Zanthoxylum myriacanthum var. pubescens) bark extract alleviates DSS-induced colitis via dual TLR4/NF-κB inhibition and intestinal barrier restoration

  2026cites this paper
• Structure-DFT-bioactivity correlation in mixed-ligand Fe(III), Mn(II), and V(IV)O complexes with bidentate NO donor 1H-benzimidazole-2-carboxylic acid and norfloxacin ligands.

  2026cites this paper
• Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.

  2026cites this paper
• RNF168 promotes chronic colitis through ANXA7-mediated autophagy and NLRP3-driven pyroptosis

  2026influential citation
• Targeting IBD treatment: smart drug delivery systems for oral administration

  2026influential citation
• Sex-specific and socioeconomic disparities in the global burden of inflammatory bowel disease in 204 countries, 1990–2021: projections to 2050

  2026cites this paper
• A chemiluminescence assay targeting granzyme A activity for monitoring inflammatory bowel disease.

  2026cites this paper
• Disease experiences and perspectives of adolescent patients with inflammatory bowel disease: a meta-synthesis of qualitative research

  2026cites this paper
• Wnt and Treg-Associated Signaling Coordinate Mucosal Regeneration and MALT Formation in a Mouse Model of Chronic Colitis

  2026cites this paper
• Role of Flavonoids as Anti-Inflammatory Agents in Inflammatory Diseases

  2026cites this paper
• TRIM29 drives ulcerative colitis by disrupting lipid metabolism via lysosomal dysfunction: a multi-omics and experimental study

  2026cites this paper
• Dismantling the Necroptotic Engine: An Oral Theranostic Nanosponge for Ulcerative Colitis.

  2026cites this paper
• Association between temperature and global incidence of inflammatory bowel disease

  2026cites this paper
• Disease-modifying efficacy of alginate-microencapsulated probiotics in an animal model of ulcerative colitis

  2026cites this paper
• Global burden of inflammatory bowel disease in Group 20 countries, 1990 to 2021: A systematic analysis with projections to 2050

  2026cites this paper
• The effects of steroid treatment on osteoporosis in patients with inflammatory bowel disease: A systematic review and meta-analysis

  2026cites this paper
• Exercise self-efficacy in young and middle-aged patients with Crohn's disease: Latent profile analysis and influencing factors.

  2026cites this paper
• Engineering bacteriophages for gut health: precision antimicrobials and beyond

  2026cites this paper
• Analysis of Periostin, TGF-β, and SLUG Expression in Inflammatory Bowel Disease in Pediatric Patients and Their Clinical Implications

  2026cites this paper
• Robinia pseudoacacia L. Flower Exosome‐Like Nanoparticles (RFELNs) Activate AhR/IL‐22 to Relieve Intestinal Barrier Dysfunction Through Regulating Gut Microbiota‐Interrelated Tryptophan Metabolism in Ulcerative Colitis Mice

  2026cites this paper
• Effect of traditional Chinese medicine on disturbances of untargeted metabolomics in ulcerative colitis.

  2026cites this paper
• The Impact of Sarcopenia on the Efficacy of Ustekinumab in Crohn's Disease.

  2026cites this paper
• Qing-Chang-Hua-Shi granule ameliorates experimental colitis by modulating Lactobacillus gasseri-mediated ferroptosis metabolic pathway

  2026cites this paper
• Loss of Epithelial Homeostasis Driven by TMBIM1 Depletion via E-Cadherin Junction Disassembly

  2026cites this paper
• A Microbial Odyssey: Reshaping Probiotic Destinies through Advanced Delivery Technologies.

  2026cites this paper
• Inhibiting METTL3 in macrophages alleviates colitis by enhancing M2 polarization via upregulating IRAKM

  2026cites this paper
• Challenges and Treatment Strategies in Elderly Patients with Inflammatory Bowel Disease: A Systematic Review and Narrative Synthesis.

  2026cites this paper
• Starch as a designable platform for oral drug delivery: From structural modulation to application in inflammatory bowel disease

  2026cites this paper
• The current consensus on ulcerative colitis, and the evidence and perspectives on the influence of gut microbiota on it

  2026cites this paper
• Transmural Healing is Associated With Higher Biological Drug Concentrations than Mucosal Healing in Crohn Disease.

  2026cites this paper
• Recent Advances in the Utilization of Dietary-Derived Exosome-like Nanoparticles in Inflammatory Bowel Diseases

  2026cites this paper
• Newly Diagnosed Crohn’s Disease After SARS‐CoV‐2 Infection

  2026cites this paper
• Hexadecanamide alleviates experimental colitis in mice and modifies the gut microbiome

  2026cites this paper
• Enteric nervous system and inflammatory bowel disease

  2026cites this paper